Mitofusin-2 gene polymorphisms and metabolic dysfunction associated fatty liver disease: a case-control study in a Chinese population

Objectives Mitofusion-2 (Mfn2) may have a role in mitochondrial oxidative stress and insulin resistance that can promote the development of metabolic dysfunction associated fatty liver disease (MAFLD). This retrospective and case control study aimed to explore the relationships between common Mfn2 single nucleotide polymorphisms (SNPs) and MAFLD in a northern Han Chinese population. Methods Six Mfn2 SNPs (rs2336384, rs873458, rs873457, rs4846085, rs2878677, and rs2236057) were genotyped using the ligase detection reaction in 466 MAFLD patients and 423 healthy controls. Genotype and allele frequencies were calculated, along with haplotype analysis and pairwise linkage disequilibrium. Results The genotype distribution of rs2336384, rs2878677, and rs2236057 among the MAFLD patients showed a significantly different pattern from that of healthy controls. The data showed that an increased risk of MAFLD was significantly correlated with patients carrying the GG genotype of rs2336384, CC genotype of rs873457, TT genotype of rs4846085, TT genotype of rs2878677, and the AA genotype of rs2236057. Moreover, The GGCTTA haplotype was found to be adversely linked with MAFLD by haplotype analysis. Conclusion The current findings suggest a strong link between certain Mfn2 gene polymorphisms and MAFLD.

[1]  G. Targher,et al.  Links between metabolic syndrome and metabolic dysfunction-associated fatty liver disease , 2021, Trends in Endocrinology & Metabolism.

[2]  R. Leube,et al.  Inflammation shapes pathogenesis of murine arrhythmogenic cardiomyopathy , 2020, Basic Research in Cardiology.

[3]  Feng Zhang,et al.  Oroxylin a promotes PGC-1α/Mfn2 signaling to attenuate hepatocyte pyroptosis via blocking mitochondrial ROS in alcoholic liver disease. , 2020, Free radical biology & medicine.

[4]  V. Wong,et al.  A new definition for metabolic associated fatty liver disease: an international expert consensus statement. , 2020, Journal of hepatology.

[5]  Hao Zhou,et al.  New insights into the role of mitochondria in cardiac microvascular ischemia/reperfusion injury , 2020, Angiogenesis.

[6]  A. Sanyal,et al.  MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease. , 2020, Gastroenterology.

[7]  C. Klinge.  Estrogenic control of mitochondrial function , 2020, Redox biology.

[8]  Kang Kim,et al.  BMP10-mediated ALK1 signaling is continuously required for vascular development and maintenance , 2019, Angiogenesis.

[9]  J. George,et al.  Genetic Insights for Drug Development in NAFLD. , 2019, Trends in pharmacological sciences.

[10]  Jinghua Liu,et al.  Single Nucleotide Polymorphisms (SNPs) Genotyping Reveals that Mfn2 Polymorphisms are Associated with Thoracic Aortic Dissection in Han Chinese Population , 2019, Medical science monitor : international medical journal of experimental and clinical research.

[11]  P. Gordon-Larsen,et al.  Epidemiology of Obesity in Adults: Latest Trends , 2018, Current Obesity Reports.

[12]  Sterling C. Johnson,et al.  Sex-specific genetic predictors of Alzheimer’s disease biomarkers , 2018, Acta Neuropathologica.

[13]  B. Neuschwander‐Tetri,et al.  Mechanisms of NAFLD development and therapeutic strategies , 2018, Nature Medicine.

[14]  Miha Mraz,et al.  LiverSex Computational Model: Sexual Aspects in Hepatic Metabolism and Abnormalities , 2018, Front. Physiol..

[15]  Guowen Liu,et al.  NEFA‐induced ROS impaired insulin signalling through the JNK and p38MAPK pathways in non‐alcoholic steatohepatitis , 2018, Journal of cellular and molecular medicine.

[16]  P. Pizzo,et al.  Mitofusin 2: from functions to disease , 2018, Cell Death & Disease.

[17]  M. Eslam,et al.  Genetics and epigenetics of NAFLD and NASH: Clinical impact. , 2018, Journal of hepatology.

[18]  Jun Ren,et al.  Empagliflozin rescues diabetic myocardial microvascular injury via AMPK-mediated inhibition of mitochondrial fission , 2017, Redox biology.

[19]  Y. Xu,et al.  Association between MFN2 gene polymorphisms and the risk and prognosis of acute liver failure: a case-control study in a Chinese population , 2017, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[20]  M. Palacín,et al.  Mfn2 deficiency links age‐related sarcopenia and impaired autophagy to activation of an adaptive mitophagy pathway , 2016, The EMBO journal.

[21]  Ya Liu,et al.  The Association of Mitofusion-2 Gene Polymorphisms with Susceptibility of Essential Hypertension in Northern Han Chinese Population , 2016, International journal of medical sciences.

[22]  V. Appanna,et al.  Dysfunctional mitochondrial bioenergetics and the pathogenesis of hepatic disorders , 2015, Front. Cell Dev. Biol..

[23]  M. Dietrich,et al.  Mitofusin 2 in POMC Neurons Connects ER Stress with Leptin Resistance and Energy Imbalance , 2013, Cell.

[24]  Chunyan Zhu,et al.  Mitofusin-2 ameliorates high-fat diet-induced insulin resistance in liver of rats. , 2013, World journal of gastroenterology.

[25]  Ying Liu,et al.  Association of Polymorphisms in Mitofusin-2 Gene with Type 2 Diabetes in Han Chinese , 2012, Journal of biomedicine & biotechnology.

[26]  Sue Fletcher,et al.  Regulation of eukaryotic gene expression by the untranslated gene regions and other non-coding elements , 2012, Cellular and Molecular Life Sciences.

[27]  M. Orešič,et al.  Mitofusin 2 (Mfn2) links mitochondrial and endoplasmic reticulum function with insulin signaling and is essential for normal glucose homeostasis , 2012, Proceedings of the National Academy of Sciences.

[28]  Shuhua Xu,et al.  Genomic dissection of population substructure of Han Chinese and its implication in association studies. , 2009, American journal of human genetics.

[29]  Yan-hong Guo,et al.  Overexpression of Mitofusin 2 inhibited oxidized low-density lipoprotein induced vascular smooth muscle cell proliferation and reduced atherosclerotic lesion formation in rabbit. , 2007, Biochemical and biophysical research communications.

[30]  S. Pocock,et al.  Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies , 2007, BMJ : British Medical Journal.

[31]  B. Gajkowska,et al.  Mitofusin 2 (Mfn2): a key player in insulin-dependent myogenesis in vitro , 2007, Cell and Tissue Research.

[32]  M. Palacín,et al.  Evidence for a Mitochondrial Regulatory Pathway Defined by Peroxisome Proliferator–Activated Receptor-γ Coactivator-1α, Estrogen-Related Receptor-α, and Mitofusin 2 , 2006, Diabetes.

[33]  Marco Castagneto,et al.  Expression of Mfn2, the Charcot-Marie-Tooth neuropathy type 2A gene, in human skeletal muscle: effects of type 2 diabetes, obesity, weight loss, and the regulatory role of tumor necrosis factor alpha and interleukin-6. , 2005, Diabetes.

[34]  L. Glimcher,et al.  Endoplasmic Reticulum Stress Links Obesity, Insulin Action, and Type 2 Diabetes , 2004, Science.

[35]  Yungang He,et al.  Genetic evidence supports demic diffusion of Han culture , 2004, Nature.

[36]  Yan-hong Guo,et al.  Dysregulation of HSG triggers vascular proliferative disorders , 2004, Nature Cell Biology.

[37]  J. Zierath,et al.  Mitofusin-2 Determines Mitochondrial Network Architecture and Mitochondrial Metabolism , 2003, The Journal of Biological Chemistry.

[38]  L. Henry,et al.  NAFLD AND NASH: Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention , 2018 .

[39]  Zhao-su Wu,et al.  HSG/Mfn2 gene polymorphism and essential hypertension: a case-control association study in Chinese. , 2011, Journal of atherosclerosis and thrombosis.

[40]  A B Rose,et al.  Intron-mediated regulation of gene expression. , 2008, Current topics in microbiology and immunology.